Literature DB >> 22912357

Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.

Leslie J Donato1, Sarah M Jenkins, Carin Smith, Jerry A Katzmann, Melissa R Snyder.   

Abstract

Laboratory evaluation of α(1)-antitrypsin (A1AT) deficiency involves measurement of circulating A1AT protein (quantitation) and characterization of A1AT genetic polymorphisms (phenotyping or genotyping). This study compared adult and pediatric A1AT reference ranges in patients with nondeficiency alleles and examined A1AT concentrations in multiple other phenotypes. A1AT phenotype and quantitation were retrospectively collected on adult (n = 21,444) and pediatric (n = 2,469) samples that were submitted for laboratory evaluation of A1AT deficiency. The 95% reference ranges for normal adult and pediatric populations with the M/M phenotype were determined to be 100 to 273 mg/dL (18.4-50.2 μmol/L) and 93 to 251 mg/dL (17.1-46.2 μmol/L), respectively (P < .0001). Decreased concentrations of A1AT correlated with heterozygosity and homozygosity for the S and Z alleles in both the adult and pediatric groups. Other rare alleles, such as I, were also associated with decreased concentrations of A1AT, particularly in the context of a Z allele, and may warrant monitoring for symptoms of deficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22912357     DOI: 10.1309/AJCPMEEJK32ACYFP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

Review 1.  Update on Alpha-1 Antitrypsin Deficiency in Liver Disease.

Authors:  Praveena Narayanan; Pramod K Mistry
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

2.  CHOP and c-JUN up-regulate the mutant Z α1-antitrypsin, exacerbating its aggregation and liver proteotoxicity.

Authors:  Sergio Attanasio; Rosa Ferriero; Gwladys Gernoux; Rossella De Cegli; Annamaria Carissimo; Edoardo Nusco; Severo Campione; Jeffrey Teckman; Christian Mueller; Pasquale Piccolo; Nicola Brunetti-Pierri
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

Review 3.  Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Authors:  Timm Greulich; Claus F Vogelmeier
Journal:  Ther Adv Respir Dis       Date:  2015-09-04       Impact factor: 4.031

4.  α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.

Authors:  A Mario Marcondes; Ekapun Karoopongse; Marina Lesnikova; Daciana Margineantu; Tobias Welte; Charles A Dinarello; David Hockenbery; Sabina Janciauskiene; H Joachim Deeg
Journal:  Blood       Date:  2014-09-15       Impact factor: 22.113

5.  Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells.

Authors:  Gregory B Pott; K Scott Beard; Courtney L Bryan; Daniel T Merrick; Leland Shapiro
Journal:  Front Public Health       Date:  2013-06-21

6.  Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency.

Authors:  Cormac McCarthy; Emmanuelle Bugnet; Amira Benattia; Michael P Keane; Benoit Vedie; Gwenaël Lorillon; Abdellatif Tazi
Journal:  Orphanet J Rare Dis       Date:  2021-02-09       Impact factor: 4.123

7.  Is the determination of C-reactive protein really necessary in the diagnosis of Alpha-1 antitrypsin deficiency?

Authors:  José María Hernández-Pérez; Claudia Viviana López-Charry
Journal:  Clin Respir J       Date:  2022-05-17       Impact factor: 1.761

8.  Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles.

Authors:  L J Donato; R M Karras; J A Katzmann; D L Murray; M R Snyder
Journal:  Respir Res       Date:  2015-08-05

9.  Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?

Authors:  Andjelo Beletic; Aleksandra Dudvarski-Ilic; Branislava Milenkovic; Ljudmila Nagorni-Obradovic; Mila Ljujic; Valentina Djordjevic; Dusko Mirkovic; Dragica Radojkovic; Nada Majkic-Singh
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313

10.  Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.

Authors:  Nan He; Xiaoming Liu; Amber R Vegter; T Idil A Evans; Jaimie S Gray; Junfeng Guo; Shashanna R Moll; Lydia J Guo; Meihui Luo; Ningxia Ma; Xingshen Sun; Bo Liang; Ziying Yan; Zehua Feng; Lisi Qi; Arnav S Joshi; Weam Shahin; Yaling Yi; Katherine N Gibson-Corley; Eric A Hoffman; Kai Wang; Christian Mueller; John F Engelhardt; Bradley H Rosen
Journal:  JCI Insight       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.